These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 22692596)
1. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Endo S; Suzuki Y; Takahashi G; Shozushima T; Ishikura H; Murai A; Nishida T; Irie Y; Miura M; Iguchi H; Fukui Y; Tanaka K; Nojima T; Okamura Y J Infect Chemother; 2012 Dec; 18(6):891-7. PubMed ID: 22692596 [TBL] [Abstract][Full Text] [Related]
2. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. Shozushima T; Takahashi G; Matsumoto N; Kojika M; Okamura Y; Endo S J Infect Chemother; 2011 Dec; 17(6):764-9. PubMed ID: 21560033 [TBL] [Abstract][Full Text] [Related]
3. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis. Lu B; Zhang Y; Li C; Liu C; Yao Y; Su M; Shou S Am J Emerg Med; 2018 Aug; 36(8):1341-1345. PubMed ID: 29276032 [TBL] [Abstract][Full Text] [Related]
4. Multicenter prospective study of procalcitonin as an indicator of sepsis. Aikawa N; Fujishima S; Endo S; Sekine I; Kogawa K; Yamamoto Y; Kushimoto S; Yukioka H; Kato N; Totsuka K; Kikuchi K; Ikeda T; Ikeda K; Harada K; Satomura S J Infect Chemother; 2005 Jun; 11(3):152-9. PubMed ID: 15990980 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. Kweon OJ; Choi JH; Park SK; Park AJ J Crit Care; 2014 Dec; 29(6):965-70. PubMed ID: 25042676 [TBL] [Abstract][Full Text] [Related]
6. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients. Plesko M; Suvada J; Makohusova M; Waczulikova I; Behulova D; Vasilenkova A; Vargova M; Stecova A; Kaiserova E; Kolenova A Neoplasma; 2016; 63(5):752-60. PubMed ID: 27468879 [TBL] [Abstract][Full Text] [Related]
7. Use of presepsin and procalcitonin for prediction of SeptiFast results in critically ill patients. Mihajlovic D; Brkic S; Uvelin A; Draskovic B; Vrsajkov V J Crit Care; 2017 Aug; 40():197-201. PubMed ID: 28432884 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis. Lin S; Huang Z; Wang M; Weng Z; Zeng D; Zhang Y; Zhu Y; Jiang J J Crit Care; 2015 Aug; 30(4):732-8. PubMed ID: 25891645 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Behnes M; Bertsch T; Lepiorz D; Lang S; Trinkmann F; Brueckmann M; Borggrefe M; Hoffmann U Crit Care; 2014 Sep; 18(5):507. PubMed ID: 25190134 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of presepsin (sCD14-ST) and procalcitonin for prediction of bacteraemia and bacterial DNAaemia in patients with suspected sepsis. Leli C; Ferranti M; Marrano U; Al Dhahab ZS; Bozza S; Cenci E; Mencacci A J Med Microbiol; 2016 Aug; 65(8):713-719. PubMed ID: 27170331 [TBL] [Abstract][Full Text] [Related]
11. Presepsin versus other biomarkers to predict sepsis and septic shock in patients with infection defined by Sepsis-3 criteria: the PREDI study of diagnostic accuracy. Contenti J; Occelli C; Lemoel F; Ferrari P; Levraut J Emergencias; 2019 Oct; 31(5):311-317. PubMed ID: 31625302 [TBL] [Abstract][Full Text] [Related]
13. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Masson S; Caironi P; Spanuth E; Thomae R; Panigada M; Sangiorgi G; Fumagalli R; Mauri T; Isgrò S; Fanizza C; Romero M; Tognoni G; Latini R; Gattinoni L; Crit Care; 2014 Jan; 18(1):R6. PubMed ID: 24393424 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal Evaluation of Plasma Concentrations of Presepsin in Patients after Severe Trauma: A Prospective Observational Study. Koch C; Ruhrmann S; Pöhlmann M; Schneck E; Arneth B; Zajonz T; Sander M; Weigand MA; Uhle F Surg Infect (Larchmt); 2018 Jul; 19(5):480-487. PubMed ID: 29683405 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department. Lai CC; Chen SY; Wang CY; Wang JY; Su CP; Liao CH; Tan CK; Huang YT; Lin HI; Hsueh PR J Am Geriatr Soc; 2010 Mar; 58(3):518-22. PubMed ID: 20163483 [TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department]. Zhao Y; Li C Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287 [TBL] [Abstract][Full Text] [Related]
17. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS Crit Care; 2007; 11(4):R76. PubMed ID: 17625012 [TBL] [Abstract][Full Text] [Related]
18. Presepsin as a predictor of septic shock in patients with urinary tract infection. Sekine Y; Kotani K; Oka D; Nakayama H; Miyazawa Y; Syuto T; Arai S; Nomura M; Koike H; Matsui H; Shibata Y; Murakami M; Suzuki K BMC Urol; 2021 Oct; 21(1):144. PubMed ID: 34641833 [TBL] [Abstract][Full Text] [Related]
19. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis. Tsujimoto K; Hata A; Fujita M; Hatachi S; Yagita M Int J Rheum Dis; 2018 Jul; 21(7):1406-1413. PubMed ID: 27291096 [TBL] [Abstract][Full Text] [Related]
20. Presepsin as a diagnostic marker of bacterial infections in febrile neutropenic pediatric patients with hematological malignancies. Baraka A; Zakaria M Int J Hematol; 2018 Aug; 108(2):184-191. PubMed ID: 29616457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]